Previous Article | Next Article ![]()
Molecular and Cellular Biology, December 2006, p. 8992-9002, Vol. 26, No. 23
0270-7306/06/$08.00+0 doi:10.1128/MCB.01311-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Department of Cell Biology and Molecular Genetics, University of Maryland, 2135 Microbiology Building, College Park, Maryland 20742
Received 18 July 2006/ Returned for modification 28 August 2006/ Accepted 11 September 2006
|
|
|---|
|
|
|---|
Although rRNAs comprise the heart of the ribosome, their molecular genetic manipulation has been much more challenging than for the ribosomal proteins. The major impediment to this line of research stems from the fact that rRNA genes have been amplified in all genomes. In Escherichia coli, strains exist in which all of the rRNA operons have been deleted, making such investigations possible in this model prokaryotic organism. It is also desirable to be able to perform similar studies with eukaryotic ribosomes. The simplest, most advanced eukaryotic model organism is the yeast Saccharomyces cerevisiae. In yeast, chromosome XII contains 100 to 200 tandemly arrayed copies of the RDN1 gene. RDN1 is an operon that contains RNA polymerase I transcribed 35S pre-mRNA, which is processed into 25S, 18S, and 5.8S rRNAs, plus RNA polymerase III transcribed gene encoding 5S rRNA. In yeast, two basic approaches have been used to address the problem of rRNA molecular genetics. One relies on coupling temperature-sensitive alleles of RNA polymerase I with a clone in which the 35S pre-rRNA is transcribed from a galactose-inducible RNA polymerase II-dependent promoter (20, 21). In theory, this approach should allow transcriptional shut off of wild-type rRNAs while inducing the synthesis of desired mutants. A parallel approach takes advantage of the observation that hygromycin can be used to select for cells that have spontaneously deleted the chromosomal RDN1 locus in favor of a plasmid-borne mutant encoding resistance to this translational inhibitor (38). The latest variations of these strains are called "rdn1
" (22, 40).
In theory, these two platforms should simplify molecular genetic analyses of the rRNAs. As witnessed by the paucity of publications describing yeast rRNA mutants over the intervening years, it is clear that something has been missing. From experience gained in our laboratory and from informal sharing of information with other researchers, it became apparent that genes expressing mutant rRNA transcripts are heavily selected against. The result is that, during the time required for auxotrophic selection for the plasmids harboring the mutant ribosomal DNA (rDNA) genes, there is strong selection against mutant rRNAs expressed from them. This places extremely strong pressure for selection of recombinant plasmids expressing both the selectable auxotrophic marker and the wild-type rRNAs. As described here, the solution to this problem is to transcriptionally silence the mutant rDNA genes during the period required for establishment of the plasmid harboring them. Only after plasmid establishment is transcription of the mutant activated and, simultaneously, transcription of the wild type is turned off. When expression of the mutant is simultaneously coupled with selection for hygromycin resistance, it is possible to establish yeast cell lines expressing only mutant rRNAs.
Here, this approach was used to generate and characterize the effects of targeted mutations in helix 38 of yeast 25S rRNA. Two specific regions of this structure were chosen for mutagenesis based on (i) known interactions with the D-loop of aa-tRNA and (ii) involvement in forming the B1a intersubunit bridge with ribosomal protein S13 in E. coli (S15 in yeast) (43). A series of viable alleles expressing only mutant rRNAs were constructed and characterized both at the biochemical and functional genetic levels. Both classes of mutants promoted approximately twofold increases in ribosomal affinities for aa-tRNAs and subtle, nucleotide-specific alterations in 25S rRNA structure. At the functional level, however, the two mutants showed differences. Single point mutants in the aa-tRNA D-loop interacting region promoted distinct temperature-sensitive phenotypes, simultaneous hypersensitivity to anisomycin, resistance to paromomycin, and decreased rates of nonsense suppression. In contrast, only a triple-base mutant in the B1a bridge-forming region promoted discernible phenotypes. These characteristics were very different from those of the first class and included simultaneous resistance to both anisomycin and paromomycin, and increased rates of nonsense codon suppression. rRNA structural analyses examining in-line cleavage patterns showed that these functionally subtle mutants produced equally subtle changes in the flexibility of unpaired or "hinge" bases in 25S rRNA. Interestingly, although deprotection of hinge bases proximal to the sites of the mutations was similar for the two mutants, the mutations differentially affected 25S rRNA structure more distally. Specifically, the tRNA D-loop-interacting mutant appeared to increase rRNA flexibility in the direction of the GTPase-associated center, while the mutant in the B1a bridge-forming mutant altered rRNA structure along the A-site proximal side of the peptidyltransferase center. These studies implicate the tip of helix 38 as contributing to the ribosome's ability to distinguish between aa-tRNA and eRF1. They also highlight distinct functional differences between two spatially close regions of helix 38 and open the door to more detailed genetic and biochemical analyses aimed to help link rRNA sequence and structure with specific functions.
|
|
|---|
was used to amplify plasmids. Yeast media and 4.7 MB plates were prepared as described previously (42); galactose media contained 2% galactose instead of glucose. Drug concentrations were as follows: doxycycline, 10 µg/ml; hygromycin B, 300 µg/ml; and anisomycin, 20 µg/ml. Yeast strain NOY1049 (MATa ade2-1 ura3-1 trp1-1 his3-11 leu2-3,112 can1-100
rDNA::his3::hisG pNOY353 (GAL7-35S rDNA, 5S rDNA, TRP1 2µm amp), was kindly provided by M. Nomura (40). The yeast killer virus [L-A HN M1] was introduced into NOY1049 by cytoplasmic mixing (9) from JD759 (MAT
kar1-1 arg1 thr1 [L-A HN M1]). Briefly, NOY1049 and JD759 cells were mixed in a ratio of approximately 1:20 on rich galactose medium and then incubated overnight at 30°C. Cells were subsequently streaked for single colonies on galactose-containing H-Arg medium and grown for 5 days at 30°C to eliminate the donor strain, i.e., JD759. Diploid cells were identified by their ability to grow on minimal medium. Colonies of NOY1049-derived cells containing the killer virus were identified by their ability to inhibit growth of a nonkiller diploid indicator strain on 4.7 MB plates containing 2% galactose as previously described (7). The resulting haploid, Killer+ strain derived from NOY1049, was designated JD1314. Its genotype is MATa ade2-1 ura3-1 trp1-1 his3-11 leu2-3,112 can1-100
rDNA::his3::hisG [L-A HN M1] pNOY353.
Restriction endonucleases were purchased from MBI Fermentas (Vilnius, Lithuania), and the rapid DNA ligation kit was obtained from Roche (Nutley, NJ). PCR amplifications were made with PfuUltra Hotstart PCR master mix (Stratagene, La Jolla, CA). DNA oligonucleotides were from IDT DNA Technologies (Coralville, IA). Standard methods were used for molecular cloning (28). The QuikChange II XL site-directed mutagenesis kit (Stratagene) was used for oligonucleotide site-directed mutagenesis. Oligonucleotide design and reaction conditions were as recommended by the manufacturer. Total yeast RNA was isolated by acid phenol extraction and treated with RNase-free DNase (QIAGEN, Valencia, CA). The Titan One-Tube RT-PCR system (Roche) was used for reverse transcription-PCR (RT-PCR). [
-32P]ATP (Perkin-Elmer, Wellesley, MA) T4 polynucleotide kinase, and avian myeloblastosis virus reverse transcriptase (Roche) were used for primer extension. Plasmid DNA and RT-PCR products were sequenced by Macrogen, Inc. (Seoul, South Korea).
Plasmid construction. The yeast high-copy-number vector pRS426 (2) was used to provide the backbone for construction of the tetracycline-controllable rRNA expression plasmid pJD694. First, a second ClaI restriction site was introduced into pRS426 after the URA3 terminator at position 1321 by oligonucleotide site-directed mutagenesis. The resulting plasmid was digested with ClaI and then religated to remove the f1 ori-containing sequences. In order to reduce the likelihood of recombination of large plasmids during passage through E. coli during subsequent genetic engineering manipulations, the MB1 replicon was replaced with the low-copy-number replication origin from pBR322. To this end, a PCR fragment containing both the pMB1 and the rop gene (which reduces plasmid copy numbers in E. coli) was amplified from pBR322, digested with BsaB1/BtsI, and cloned into yeast vector at SmaI/BtsI restriction sites. Next, a TET cassette with two tetO repeats derived from pCM188 (10) was subcloned into the EcoRI/HindIII-digested vector backbone. For the next step, a 525-bp HindIII tailed PCR product containing the RDN5 gene amplified from pJD180 (31) was cloned into the HindIII site of the plasmid. The resulting plasmid (pJD690) served as an empty vector control. A 6,948-bp DNA fragment encoding the primary 35S rRNA transcript (from the transcription start at +1 to the enhancer region at +6922 [21]) and which contained flanking NotI and BamHI restriction sites was synthesized by PCR from pJD180. This product was cloned into NotI/BamHI-digested pJD690 downstream of the TET cassette and in the opposite transcriptional orientation relative to RDN5. The resulting plasmid was designated pJD692. A base substitution in RDN18 promoting hygromycin resistance (37) was introduced into pJD692 by site-directed mutagenesis to make the final construct, pJD694. This is also referred to as pTET. The RDN5 and 35S rDNA regions were confirmed by DNA sequencing. The complete sequence of pJD694 is available upon request. Subsequent mutations in rDNA encoding regions of pJD694 were introduced by oligonucleotide site-directed mutagenesis, and all mutations were confirmed by sequencing.
Yeast genetic manipulations. Transformations of yeast strain JD1314 were performed according to an alkaline cation protocol (16). Yeast cells were grown at 30°C unless otherwise indicated. Transformants were selected after 7 days of growth on galactose-containing Trp Ura medium with doxycycline (gal Trp Ura +Dox). Colonies were then streaked on gal Trp Ura +Dox plates and incubated for 2 days. Under these conditions, only wild-type rRNA transcribed from the GAL7 promoter was expressed, allowing establishment of the pJD694-based plasmids while silencing transcription of mutant rRNAs. Cells were then replica plated on YPAD medium to turn off transcription of the wild-type 35S rRNA from the pGAL plasmid and to turn on transcription of mutant 35S rRNAs from the pJD694-based plasmids. Colonies were simultaneously replica plated onto control plates: YPAGal, YPAGal+Dox, and YPAD+Dox. On the following day, colonies were again replica plated on the same media and incubated for 2 days, thus eliminating residual growth of cells caused by wild-type ribosomes during the transition of rRNA transcription from GAL-regulated to TET-regulated promoters. Yeast cells growing on YPAD medium were then replica plated onto YPAD medium supplemented with hygromycin B (YPAD+Hyg) and grown for 2 days. This step was to select for a pure population of yeast expressing rRNA from the pJD694-based plasmids while simultaneously selecting against cells containing wild-type rRNA, which could either remain after switching rRNA expression templates and/or be caused by leaky expression from the GAL7 promoter. These growth conditions also select only for maintenance of the pJD694-based plasmids and encourage the spontaneous loss of pNOY353. Cells were subsequently passaged three more times on YPAD+Hyg and streaked for single colonies on the same medium to ensure elimination of pNOY353. After 7 days, colonies were replica plated onto YPAGal+Dox, Gal Trp Ura +Dox, or YPAD medium. After 2 days, clones that grew on YPAD plates but not on galactose-containing media were inoculated into 3 ml of liquid YPAD and cultured in a shaking incubator for 24 h. Subsequently, 2.5 µl of saturated yeast suspension was spotted onto either YPAGal, YPAGal+Dox, YPAD, or YPAD+Dox medium and grown for 2 days to assess the efficiency and/or quality of pGAL plasmid elimination. Pure cultures of cells that were viable in YPAD but not in both YPAGal+Dox and YPAD+Dox were used for subsequent genetic assays and isolation of total RNA. Aliquots of these cells were frozen at 80°C as a glycerol stock.
Genetic assays. Genetic assays were performed with selected clones containing the pJD694-based plasmids as sole sources of rDNA. Overnight cultures of yeast were used for subsequent genetic assays. General growth defects were monitored by dilution spot assay. Five sets of 10-fold dilutions were made, and 2.5 µl of each suspension was spotted onto the YPAD medium to yield a range of spots from 105 to 101 CFU/spot. Plates were incubated at 20, 30, and 37°C. For drug disk assays, overnight yeast cultures were diluted to an optical density at 592 nm of 0.2, and 300-µl portions of the resulting suspensions were plated onto YPAD medium. Subsequently, 10-µl portions of solutions containing 2 mg of anisomycin/ml or 500 mg of paromomycin/ml were applied to 6-mm-diameter filter paper discs, and the discs were air dried and placed on a plated lawn. Plates were incubated at 30°C for 3 days, and the diameters of the growth inhibition zone were measured. A minimum of at least two independent assays were used. The ability of cells to suppress a UAA nonsense codon utilized the pYDL-UAA dual luciferase reporter constructs as previously described (13). At least three readings were taken for each assay, and all assays were repeated (n = 3 to 12) until the data were normally distributed to enable statistical analyses both within and between experiments (17).
Polysome profiles and aa-tRNA binding assays. Lysates of cycloheximide-arrested yeast cells were sedimented through 7 to 47% sucrose gradients, and polysome profiles were determined by monitoring the A254 as previously described (27). Yeast phenylalanyl-tRNA was purchased from Sigma (St. Louis, MO), charged with [14C]Phe, and purified by high-pressure liquid chromatography as previously described (18). Ribosomes were isolated from isogenic wild-type and mutant cells, and aa-tRNA binding studies were carried out as previously described (18). Nonlinear regression analysis of binding data was performed with GraphPad Prism 4.0 software (GraphPad Software, San Diego, CA). Two models were tested: (i) binding with ligand depletion and (ii) binding with both ligand depletion and nonspecific binding. The terms used in the equations below are defined as follows: [tRNA], free tRNA concentration; [tRNA0], initial concentration of tRNA; [RS], free ribosome concentration; [RS0], initial ribosome concentration; [tRNA-RS], concentration of tRNA-ribosome complex; and NS, nonspecific binding.
In the first model, the concentration of free ligand is significantly different from the initial ligand concentration. Application of [tRNA] = [tRNA0] [tRNA-RS] and [RS] = [RS0] [tRNA-RS] substituted into the Kd definition equation (Kd = [RS] · [tRNA]/[tRNA-RS]; [tRNA-RS] = [RS] · [tRNA]/Kd) yields the following: [tRNA-RS]2 [tRNA-RS]([RS0] + [tRNA0] + Kd) + [RS0][tRNA0] = 0.
Solution of the second-order equation results in [tRNA-RS] = (b b24c)/2, where b = ([RS0] + [tRNA0] + Kd) and c = [RS0][tRNA0]. The binding data was fitted into this equation constraining [RS0] and Kd to positive values.
In the second model (binding with both ligand depletion and nonspecific binding), nonspecific binding can be viewed as linear in the range of the [tRNA] concentrations used. Thus, [tRNA-RS] = ([RS] · [tRNA]/Kd) + NS[tRNA] (34). Application of [tRNA] = [tRNA0] [tRNA-RS] and [RS] = [RS0] [tRNA-RS] substituted into this equation produces the following: [tRNA-RS]2 [tRNA-RS]([RS0] + [tRNA0] + Kd) + [RS0][tRNA0] = 0.
Solution of the second-order equation results in [tRNA-RS] = (b b24ac)/2a, where a = 1 + NS, b = ([RS0] + [tRNA0] + Kd + KdNS + 2[tRNA0]NS), and c = [tRNA0](KdNS + [tRNA0]NS + [RS0]). The binding data was fitted into this equation with [RS0], Kd, and NS constrained to positive values. Comparison of the results generated from both tests revealed that the second test provided the best fit to the equilibrium binding curves. Thus, the data generated using the second model (binding with ligand depletion and nonspecific binding) are reported in the Results.
Chemical protection and rRNA in-line cleavage analyses. Chemical probing with dimethyl sulfate (DMS), kethoxal, and carbodiimide metho-p-toluenesulfonate (CMCT), followed by reverse transcriptase primer extension analyses of modified rRNAs, was performed as previously described (33), with the modification that reactions were performed at 30°C instead of 37°C. The following primers were used: H38 (5'-GCTCTTCATTCAAATGTCCACG-3'), 25-2 (5'-GACTTCCATGGCCACCG-3'), 25-4 (5'-TAAAGGATCGATAGGCC-3'), 25-6 (5'-AACCTGTCTCACGACGG-3'), 25-7 (5'-CCTGATCAGACAGCCGC-3'), and A108 (5'-AGATTGCAGCACC-3'). Primer extensions from H38 covered helix 38, primer 25-2 covered bases from helices 39 to 42, primer 25-4 allowed analyses spanning helices 83 to 87, primer 25-6 covered helices 89 to 93, primer 25-7 covered bases from helices 93 to 95 of 25S rRNA, and primer A108 from 5S rRNA. For rRNA in-line cleavage assays, 150 pmol of ribosomes was incubated at 30°C in 400 µl of 50 mM Tris (pH 7.4), 5 mM Mg(CH3COO)2, and 50 mM NH4Cl. At time points of 0, 3, 6, and 12 h, 100-µl aliquots of ribosome suspensions were removed, and rRNAs were phenol extracted and used for reverse transcriptase primer extension with the H38 DNA primer. Aliquots of the reactions were separated through 8% sequencing gels and imaged by using a Molecular Imager FX (Bio-Rad).
|
|
|---|
The genetic scheme is diagrammed in Fig. 1. Beginning with rdn1
cells growing in galactose-containing medium expressing wild-type rRNAs from the galactose-inducible promoter on a high-copy TRP1 selectable plasmid (pNOY353/pGAL), cells are transformed with plasmid harboring mutant rDNA genes under control of the Tetr promoter on a high-copy URA3 selectable plasmid (pJD694/pTET), and transformants are selected for on medium lacking uracil and containing galactose and doxycycline (a stable tetracycline analog). This selects for the establishment and maintenance of the URA3-based pTET but prevents simultaneous selection against the 35S mutant allele that it contains. Once colonies have grown, these are transferred to rich medium (YPAD) containing glucose instead of galactose, conditions that allow transcription of the mutant 35S rRNA while shutting off transcription of the wild-type gene. In a third step, cells were replica plated onto rich glucose medium with hygromycin to further drive selection against remaining wild-type ribosomes and/or leaky expression of wild-type 35S transcripts. This protocol yielded colonies that were unable to grow in the presence of doxycycline, resistant to hygromycin, and viable with glucose as the sole carbon source. These results provided the initial proof of principle of the utility of the genetic manipulation strategy. pJD694 was used for subsequent oligonucleotide site-directed mutagenesis to create alleles containing mutations at specific bases of 25S rRNA.
![]() View larger version (11K): [in a new window] |
FIG. 1. (a) High-copy plasmids for episomal expression of rRNAs in rdn1![]() cells. In the TRP1-selectable pGAL series, transcription of 35S pre-rRNA is driven from the GAL7 promoter, and transcription termination is effected by sequences in the GAL7 3' untranslated region. In the URA3-selectable pTET series, transcription is controlled by a tetracycline-repressible promoter and transcription termination is mediated by sequences in the CYC1 3' untranslated region. A mutation in 18S rRNA conferring recessive hygromycin resistance was added to enable selection for rRNAs produced from this plasmid. Mutations of interest are incorporated into rDNA sequences by oligonucleotide site-directed mutagenesis. (b) Three-step protocol for selection of cells expressing only mutant forms of rRNAs. Step 1 selects for the transformation of pGAL containing cells with pTET plasmid, while repressing expression of mutant rRNA species. During step 2, transcription of wild-type rRNA from pGAL is repressed, and transcription of mutant rRNA is derepressed. This step enables spontaneous loss of the pGAL. Step 3 is used to select against any wild-type rRNAs that may have resulted from recombination between the two plasmids or from leaky expression from pGAL or survived through multiple cell generations.
|
![]() View larger version (36K): [in a new window] |
FIG. 2. Locations of yeast 25S rRNA mutants characterized in the present study. Nucleotide sequence of the distal end of yeast helix 38 (the A-site finger [ASF]) is shown using S. cerevisiae 25S rRNA numbering. Mutagenized bases are blocked in color. The local atomic resolution structure of the E. coli ribosome (39) using PDB files 1PNS and 1PNU were modeled by using PyMOL (6). The aa-tRNA is depicted in orange, and the anticodon (AC) and D-loops (D) are indicated. Small ribosomal protein S15 is the yeast equivalent of E. coli S13. Mutagenized bases in helix 38 are colored.
|
![]() View larger version (56K): [in a new window] |
FIG. 3. Example of selection for cells expressing only mutant forms of rRNAs. (a) The top panel shows rdn1![]() cells transformed with the indicated pTET plasmids grown on the indicated media. The bottom panel shows the growth phenotypes of cells in the presence of hygromycin B. Yeast expressing rRNA only from pTET plasmids (indicated by lines) were transferred on series of media containing hygromycin B. (b) Cells express only mutant 25S rRNA alleles. On the left is an autoradiogram of direct sequence analysis of rRNA for the A1026C allele. On the right are automated sequence tracings of cDNA clones made from rRNAs isolated from the indicated alleles.
|
![]() View larger version (32K): [in a new window] |
FIG. 4. Phenotypic analyses of helix 38 mutants. (a) Tenfold dilution spot assays showing growth phenotypes of G1019N, G1020N, G1021N, and AAA(B1a)CCC alleles at 30 and 37°C. (b) Drug sensitivity phenotypes. Diameters of zones of cellular growth inhibition around 6-mm discs containing either 20 µg or anisomycin or 2.5 mg of paromomycin are indicated.
|
Both the AAA(B1a)CCC and G1020C alleles result in increased ribosomal affinity for aa-tRNAs. Given the physical interactions between the A-site and helix 38 and the effects of the two classes of mutants on translational fidelity, it was reasonable to hypothesize that ribosomes harboring these mutants may have altered affinities for aa-tRNAs. To test this, aa-tRNA binding to the ribosomal A-site was determined for purified wild-type ribosomes and for those containing the AAA(B1a)CCC and G1020C mutations. Care was taken to block nonspecific binding of [14C]Phe-tRNA to ribosomal E- and P-sites by preincubating ribosomes with uncharged tRNAs. The results of these experiments demonstrate that the Kd values for wild-type, G1020C, and AAA(B1a)CCC ribosomes were 20.2 ± 2.6, 12.6 ± 1.5, and 13.36 ± 1.4 nM, respectively (Fig. 5). Polysome profiles revealed no significant differences between the wild type and the two mutants (data not shown).
![]() View larger version (13K): [in a new window] |
FIG. 5. aa-tRNA binding studies. aa-tRNA binding to A-site of ribosome was carried out in 100-µl reaction mixtures containing 25 pmol of ribosomes primed with 25 µg of poly(U). Reaction mixtures were preincubated with 10 µg of uncharged tRNAs at 30°C for 30 min to ensure full occupation of P-sites by uncharged tRNA, after which increasing amounts of (1 to 128 pmol) of [14C]Phe-tRNA were added. Incubations continued for 10 min at 30°C to allow the formation of [14C]Phe-tRNA · 80S · poly(U) complexes. Reaction mixtures were applied onto nitrocellulose membranes, filters were washed with binding buffer, and radioactivity was measured by scintillation counting. Binding isotherms were fitted to the data (a) and Kd values (b) were calculated by using GraphPad Prism 4 as described in Materials and Methods.
|
![]() View larger version (39K): [in a new window] |
FIG. 6. rRNA structural analyses. Sequencing ladders and primer extensions were generated with avian myeloblastosis virus reverse transcriptase using rRNAs isolated from ribosomes. Un, untreated samples; DMS, ribosomes treated in vitro with DMS; Ket, ribosomes treated in vitro with kethoxal; CMCT, ribosomes treated in vitro with CMCT. (a) Direct sequencing of the distal tip of helix 38 from rRNAs extracted from cells expressing the wild-type, G1020C, or AAA(B1a)CCC alleles. (b) Structure probing of helix 38. Individual nucleotide positions of bases in mutant samples showing enhanced in line rRNA cleavage are indicated by arrows. The asterisk indicates a strong stop at nucleotide 1021 in the G1020C mutation. (c) Time course in-line cleavage experiments. Equal amounts of freshly prepared ribosomes purified from isogenic wild-type and mutant cells were incubated at 30°C in buffer without chemical modifying agents for 0, 3, 6, and 12 h, after which rRNAs were extracted, used for reverse transcriptase primer extension with the primer described above, and separated through an 8% acrylamide-urea gel. (d) Structure probing of helix 41. The asterisks indicate enhanced in-line cleavage at A1178 specific to the G1020C mutant. (e) Structure probing along helix 91. Asterisks indicate enhanced in line cleavage of bases in the AAA(B1a)CCC mutant.
|
Over the course of a large number of chemical protection and RT primer experiments, we observed that the intensity of the bands at these sites increased in proportion with both of the ages of the ribosome preparations, i.e., weaker banding patterns were observed with freshly prepared ribosomes versus samples that had been stored at 80°C. These observations are consistent with the hypothesis that the mutants were affecting the in-line cleavage of specific unpaired bases in helix 38. To further investigate the in-line cleavage effect, a series of time course experiments were performed with untreated ribosomes. Equal amounts of freshly prepared ribosomes purified from isogenic wild-type and mutant cells were incubated at 30°C in buffer without chemical modifying agents for 0, 3, 6, and 12 h, after which rRNAs were extracted and used for reverse transcriptase primer extension using the H38 DNA primer. The results of this experiment are shown in Fig. 6c. Examination of the nonspecific bands in the lower portion of the figure shows that all samples contained equal amounts of rRNA. The remainder of the figure reveals base-specific increases or decreases in sensitivity to self-cleavage over time as at the same positions observed in the untreated, single-time-point samples shown in Fig. 6b. These results are consistent with the hypothesis that the G1020C and AAA(B1a)CCC mutants were exerting subtle, long-range effects on the structure of helix 38. Increased mutant specific in-line reactivities were also observed more distal to the sites of the mutations. The G1020C allele affected the stability of G1178, which is located in a bend of helix 41 (Fig. 6d). Increased in-line in AAA(B1a)CCC specific reactivity was also observed in helix 91 along the A-site proximal side of the peptidyltransferase center at bases A2886 and A2899 (Fig. 6e).
|
|
|---|
10% of colonies containing only wild-type ribosomes. Thus, care must be taken to initially sequence a few samples of ribosomes extracted from cells derived from single colonies. However, once established, these alleles were as genetically stable as any other yeast mutants (i.e., spontaneous revertants and probable second-site suppressors were observed with normal frequencies). Second, at an observational level we noted that isogenic rdn1
cells in which 35S rRNAs are transcribed from either pGAL or pTET tend to grow more slowly than cells in which 35S rRNAs are transcribed from the native promoter. This could be due to limiting quantities of RNA polymerase II, differences in relative promoter strengths, or differences in chromatin structure affecting rRNA transcription rates. Experiments are ongoing to investigate this phenomenon and to generate a more robust system for producing yeast cells that express only mutant forms of 25S rRNA.
Helix 38 structure-function analyses.
Studies in E. coli have examined both components of the B1a bridge. Deletion of the C-terminal tail of the small subunit partner S13 was viable, although cell doubling times were increased
2-fold, and in vitro studies showed that the P-site of this mutant had decreased affinity for tRNA (15). Reconstituted ribosomes completely lacking S13 were translationally competent but were refractive to thiol-modifying reagents, suggesting that S13 is involved in controlling EF-G-independent features of translocation (4). A follow-up study using S13-deficient E. coli revealed roles for this protein in subunit association, formation of translation initiation complexes, factor-dependent translocation, reading frame maintenance, and termination codon recognition (3). A complementary study focusing on the other side of the B1a bridge in E. coli showed that deletion of approximately one-third of the distal tip of helix 38 yielded ribosomes that were viable, and genetic analyses of this mutant revealed no significant functional differences in any of the basic steps of the elongation cycle (30). However, a small decrease in EF-G-stimulated GTPase activity was observed, and chemical probing experiments revealed changes in bases of 5S rRNA and in the large subunit rRNA located between the peptidyltransferase center and the elongation factor binding site. All of these findings support the hypothesis that this structure may be involved in the fine tuning of ribosomal activity (3) and that the B1a bridge may function as part of an allosteric communication pathway between the large and small subunits (30).
Although spatially close to one another, the two stretches of three nucleotides examined in the present study interact with different structures in the ribosome. This is reflected by both similarities and differences in their functional phenotypes. For example, neither class of mutants affected the ability of cells to maintain the yeast killer virus (a proxy monitor for changes in translational reading frame maintenance [see reference 7]). These observations are consistent with the E. coli helix 38 deletion studies, suggesting that this structure does not play a major role in elongation (30). However, the two classes of mutants examined in the present study did affect other aspects of translation, in some cases to similar extents, but dissimilarly in others. For example, heat sensitivity is suggestive of destabilization of intra- and/or intermolecular interactions, which is consistent with the observed frequencies of in-line cleavage of specific unpaired bases. The drug sensitivity and nonsense suppression assays were particularly interesting in that they yielded dissimilar and novel phenotypes. Anisomycin is known to promote decreased affinity for aa-tRNA by competing for their mutual binding site in the peptidyltransferase center (11, 12). Conversely, paromomycin can suppress nonsense mutations by increasing the affinity of noncognate aa-tRNAs termination codons in the decoding center (reviewed in reference 24). That both mutants were resistant to paromomycin but had opposite phenotypes in response to anisomycin suggests subtle, but differing functions of these two regions of the A-site finger in translational fidelity. That their effects on aa-tRNA affinity are similar may reflect cumulative effects on this function of the ribosome. However, aa-tRNAs interact with many different parts of the ribosome, suggesting that the changes in the quality of the interactions between the ribosome and aa-tRNA interactions may be more important than quantitative changes. The opposing effects of the mutants on the suppression of a nonsense codon are particularly informative. Like the S13 deletion studies (3), these findings implicate this region of helix 38 in factor-dependent ribosome function, i.e., eRF1/eRF3-mediated translation termination. Interestingly, although both the B1a bridge and G1020 may function as sensors of the A-site, they may differ in their specificity with regard to whether the A-site is occupied by aa-tRNA or eRF1. The in-line cleavage pattern of the AAA(B1a)CCC mutant showing increased flexibility of the hinge bases in helix 91 along the path of accommodation of the aa-tRNA (29) is particularly interesting in this aspect. We suggest that increased affinity of aa-tRNA in this mutant may be due to a more flexible rRNA environment, which may in turn lessen the ability of ribosomes to discriminate between a codon-anticodon base pair versus the eRF1-termination codon interaction. With regard to G1020C, we speculate that this mutant is more discriminatory with regard to the differences between the tRNA D-loop and the analogous topological region of eRF1. Thus, in this mutant, an increased ability to discriminate between the presence or absence of the D-loop may affect signal transmission to the GTPase-associated center, accounting for the altered reactivity of G1178 and the enhanced ability to discriminate between sense and nonsense codons. The opposing nonsense suppression and anisomycin sensitivity phenotypes and the allele-specific differences in in-line cleavage patterns (discussed below) presented by the two mutants in the present study provide supporting evidence for this model.
Significant rearrangements of rRNA elements have been demonstrated depending on the stage of the elongation cycle during which the ribosome samples were stalled (1, 8, 23, 35, 36, 44). More recently, a study examining elongation arrest by the SecM peptide in E. coli ribosomes has shown that these rRNA rearrangements proceed through a cascade of events (19). The question is, what is it about the architecture of rRNA that allows such cascades to occur, thus enabling the coordination of information sharing among spatially separate regions of the ribosome? It has been suggested that single-stranded regions of rRNAs, called RNA kink turns, can function to confer flexibility on more rigid helical rRNA protuberances. RNA kink-turn motifs have been likened to "molecular hinges" that allow large motions and/or smooth assembling of large portions of the ribosome (25, 26). When the bases in which in-line cleavage patterns are enhanced by the two mutants are mapped onto the atomic resolution ribosome structure, a striking pattern emerges: they appear to form a precisely spaced series of points forming an arc surrounding the tRNA binding pocket of the large subunit (Fig. 7). A simple "connect the dots" exercise suggests a large-scale communication bridge connecting the decoding center on the small subunit (the C-terminal tail of S15), with the large subunit through the B1a bridge, to the aa-tRNA D-loop, and up the body of the A-site finger. The allele-specific differences suggest a functional bifurcation. G1178 lies in a bend of helix 41, along the pathway to the GTPase-associated center. The increased reactivity of this base in the G1020C mutant suggests a functional link between the D-loop interacting region of helix 38 and the GTPase-associated center. A2886 and A2899 form a bend at the base helix 91 in the peptidyltransferase center and at its distal tip, respectively. This latter base interacts with the sarcin/ricin loop, which in turn interacts with elongation factors.
![]() View larger version (34K): [in a new window] |
FIG. 7. An arc of unpaired "hinge bases" facilitate information exchange among functional centers of the ribosome. The illustration at the top of the figure is a two-dimensional map showing the regions of yeast 25S rRNA of interest. Bases boxed in green show enhanced in-line cleavage in the 25S rRNA mutants. A2819 in the core of the peptidyltransferase center is blocked in red. Helices and expansion segments are indicated. The locations of every 50th base are labeled, and every 10th base is indicated by tick marks. The arrow indicates the direction to the GTPase-associated center (GAC). The lower diagram shows the positions of bases of interest modeled onto the atomic resolution structure of the E. coli ribosome (39). The labeling follows the conventions described in Fig. 2. The peptidyl-tRNA (p-tRNA) is gray, aa-tRNA is orange, the helices 32, 37, 38, and 41 are red, helix 91 is blue, and the sarcin/ricin loop (SRL) is purple. Hinge bases are shown as green spheres, and A2819 is shown in red.
|
This study was supported by a grant from the Public Health Service to J.D.D. (GM58859).
Published ahead of print on 25 September 2006. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»